CADM2 and esophageal squamous cell carcinoma: &lt;i&gt;ADAMTS9-AS2&lt;/i&gt; acts as an epigenetic brake to constrain DNMT3B-mediated &lt;i&gt;CADM2&lt;/i&gt; silencing in esophageal squamous cell carcinoma metastasis.